# Organon & Co. (OGN)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/organon-and-co/ JSON: https://steadybase.io/company/organon-and-co.json Checked Nov 10, 2026. Latest filing read: Oct 30, 2026.

## Company

- Legal name: Organon & Co.
- Ticker: OGN (NYSE)
- SEC CIK: 0001821825
- Industry: Pharmaceutical Preparations (SIC 2834)
- Headquarters: Jersey City, NJ
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: organon.com
- LinkedIn: https://www.linkedin.com/company/organon
- Next earnings date: Nov 9, 2026

## Key facts

- Revenue: $6.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/0001628280-26-011125-index.html
- Net income: $187.0M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/0001628280-26-011125-index.html
- SG&A: $1.7B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/0001628280-26-011125-index.html
- Employees: 10,000 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Shares outstanding: 262,621,584 as of Oct 23, 2026 (10-Q filed Oct 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1821825/000182182526000004/0001821825-26-000004-index.html
- Auditor: Pricewaterhousecoopers LLP, Florham Park, New Jersey, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm

## Business

Organon & Co. (“Organon,” the “Company,” “we,” “our,” or “us”) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across women’s health and general medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 countries and territories.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Net income | SG&A |
|---|---|---|---|
| Dec 31, 2025 | $6.2B | $187.0M | $1.7B |
| Dec 31, 2024 | $6.4B | $864.0M | $1.8B |
| Dec 31, 2023 | $6.3B | $1.0B | $1.9B |
| Dec 31, 2022 | $6.2B | $917.0M | $1.7B |
| Dec 31, 2021 | $6.3B | $1.4B | $1.7B |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/organon-and-co.json

## Officers and directors

- Joseph T. Morrissey Jr., Interim CEO. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023127/0001628280-26-023127-index.htm
- Matthew M. Walsh, Chief Financial Officer. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023157/0001628280-26-023157-index.htm
- Matthew Walsh, Chief Financial Officer. LinkedIn: https://www.linkedin.com/in/mmwalsh-cfo. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Lynette Holzbaur, SVP and Corporate Controller. Source: 4/A filed May 7, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026032059/0001628280-26-032059-index.htm
- Aaron Falcione, Chief Human Resources Officer. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023150/0001628280-26-023150-index.htm
- Rachel A. Stahler, Chief Information Officer. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023166/0001628280-26-023166-index.htm
- Carrie Cox, Executive Chair of the Board of Directors. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Carrie Smith Cox, Executive Chair. Source: Form 4 filed Nov 13, 2025, https://www.sec.gov/Archives/edgar/data/1821825/000162828025052004/0001628280-25-052004-index.htm
- Ferreira Juan Camilo Arjona, Head of R&D & CMO. Source: Form 4 filed Aug 12, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026056061/0001628280-26-056061-index.htm
- Juliana Papa Drinane, Head of Mfg & Supply. Source: Form 4 filed Aug 5, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026053306/0001628280-26-053306-index.htm
- Daniel Karp, Executive VP, Corp. Dev.. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023180/0001628280-26-023180-index.htm
- Kirke Weaver, Gen. Counsel & Corp. Secy.. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023146/0001628280-26-023146-index.htm
- Vittorio Nisita, Head of Global Business Svcs. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026023143/0001628280-26-023143-index.htm
- Alan Ezekowitz, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Cynthia Patton, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Deborah Leone, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Helene Gayle, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Philip Ozuah, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Ramona Sequeira, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Robert Essner, Lead Independent Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Rochelle Lazarus, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Shalini Sharp, Director. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- Carrie S. Cox, Board member (per proxy). Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000119312526177411/ogn-20260423.htm
- Cynthia M. Patton, Board member (per proxy). Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000119312526177411/ogn-20260423.htm
- Helene Gayle, M.D., M.P.H., Board member (per proxy). Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1821825/000119312526177411/ogn-20260423.htm

## Recent 8-K events

- Oct 30, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926120423/tm2628576d1_8k.htm
- Jul 31, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926089008/tm2621744d1_8k.htm
- Jul 23, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1821825/000119312526314587/d128953d8k.htm
- Jul 17, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1821825/000119312526307767/d88294d8k.htm
- Jun 11, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926072953/tm2617690d1_8k.htm
- Apr 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926052165/tm2613165d1_8k.htm
- Apr 27, 2026: Item 1.01, Entry into a material definitive agreement; Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000119312526178718/d38652d8k.htm
- Feb 20, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926017870/tm266880d1_8k.htm
- Feb 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465926013888/tm266144d1_8k.htm
- Nov 10, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1821825/000110465925108821/tm2530711d1_8k.htm

## Insider trades (Form 4)

- Aug 5, 2026: Juliana Papa Drinane (Head of Mfg & Supply) sold 14,761 shares, about $200,307. Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026053306/0001628280-26-053306-index.htm
- May 6, 2026: Lynette Holzbaur (SVP and Corporate Controller) bought 26,448.37 shares, about $353,086. Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828026031780/0001628280-26-031780-index.htm
- Nov 12, 2025: Carrie Smith Cox (Executive Chair) bought 65,400 shares, about $501,618. Source: https://www.sec.gov/Archives/edgar/data/1821825/000162828025052004/0001628280-25-052004-index.htm

## Latest filings

- 8-K filed Oct 30, 2026: https://www.sec.gov/Archives/edgar/data/1821825/000110465926120423/tm2628576d1_8k.htm
- 10-K filed Feb 24, 2026: https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm
- 10-Q filed Oct 30, 2026: https://www.sec.gov/Archives/edgar/data/1821825/000182182526000004/ogn-20260930.htm
- DEF 14A filed Apr 24, 2026: https://www.sec.gov/Archives/edgar/data/1821825/000119312526177411/ogn-20260423.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/